Phreesia, Inc.

Phreesia Named to TIME’s 2026 List of the World’s Top HealthTech Companies

Phreesia was named to TIME's 2026 list of the World's Top HealthTech Companies, its second consecutive year on the list, earning a "Very High" rating in the Health Information & Management category. The list is developed with Statista, evaluating companies on financial performance, reputation, and online engagement. CEO Chaim Indig noted Phreesia supported 1 in 6 U.S. patient visits, with more than 180 million patient visits enabled in 2025. The recognition is reputational and carries no direct financial impact.

•25d ago

Phreesia’s ProviderConnect Audiences are Now Available in the DeepIntent Audience Marketplace

Phreesia announced a partnership with DeepIntent, placing its ProviderConnect audiences inside the DeepIntent Audience Marketplace for healthcare marketers. ProviderConnect targets clinicians based on cases they are likely to see in upcoming practice, using privacy-centered, real-world care insights drawn from Phreesia's ecosystem, which enabled more than 180 million patient visits in 2025, or 1 in 6 U.S. visits. The deal gives Phreesia a turnkey activation channel alongside DeepIntent's data capabilities; no financial terms were disclosed.

•1mo ago

PHR: 10-Q · periodic report

Phreesia filed its 10-Q for the quarter ended July 31, 2026, reporting revenue of $129.5 million, up 10% year over year, with net income of $1.9 million versus $0.7 million in the prior-year quarter. First-half revenue rose 12% to $260.4 million, and the company swung to net income of $4.9 million from a $3.3 million loss a year earlier; Adjusted EBITDA climbed to $63.4 million from $42.9 million and free cash flow to $30.2 million from $17.1 million. Growth is being driven by the AccessOne acquisition, which closed November 12, 2025, with payment solutions revenue reaching $38.5 million versus $28.4 million of legacy payment processing fees a year ago; Phreesia repaid its $110 million bridge loan and moved to a $275 million Capital One revolver, with $60.7 million drawn at 6.4% as of July 31, 2026. Watch items include a restructuring plan eliminating roughly 220 positions with about $10 million in expected charges, a $4.95 million ConnectOnCall data breach settlement awaiting final court approval on November 17, 2026, and two securities class actions where losses cannot yet be estimated.

SEC 10-Q•1mo ago

Phreesia Announces Second Quarter Fiscal 2027 Results

Phreesia posted fiscal Q2 2027 revenue of $129.5 million, up 10% year-over-year, with GAAP net income of $1.9 million ($0.03 diluted EPS) versus $0.7 million a year earlier. Adjusted EBITDA climbed to $32.9 million from $22.1 million, and free cash flow of $13.8 million helped cut debt principal by over $23 million, leaving $61 million outstanding on the Capital One credit facility against $74.6 million in cash. Management maintained its fiscal 2027 outlook — revenue of $510-$520 million and Adjusted EBITDA of $125-$135 million, assuming roughly $37 million from AccessOne — while flagging more variability in network solutions revenue forecasting in the second half. The May 2026 restructuring plan eliminating roughly 220 positions carries about $10 million in expected charges with $2.8 million recognized this quarter, and management pointed to AccessOne, ProviderConnect and AI investments as future growth drivers.

•1mo ago

Phreesia and March of Dimes Partner to Help Strengthen Physician-Patient Conversations and Improve the Health of Moms and Babies

Phreesia partnered with March of Dimes to integrate evidence-based educational content into its patient intake platform, specifically targeting prenatal and postpartum care. The collaboration aims to raise awareness of conditions like preeclampsia and postpartum depression, leveraging Phreesia’s network which enabled 180 million patient visits in 2025. By delivering resources to both patients and providers before appointments, the initiative seeks to improve maternal health outcomes through better-informed clinical conversations.

•3mo ago

MediFind Launches AI-Powered Chatbot to Help Patients Find and Book the Right Provider

Phreesia’s MediFind subsidiary launched Chloe, an AI-powered chatbot designed to guide patients step-by-step through finding and booking the right medical provider. The tool captures patient information upfront to surface tailored matches from MediFind’s database of more than 2 million clinicians. By streamlining the intake process, the chatbot aims to reduce incorrect bookings and help patients with complex or rare conditions find experts more efficiently.

•3mo ago